PharmaBoardroom

Digital Therapeutics Need the Scrutiny of All Health Stakeholders

Carla Smith is a healthcare thought leader with nearly 30 years' experience. She champions transformational strategy, governance, and policy in the…

10 Pharma Leaders to Know in India

Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe, hence the reason India has been dubbed…

Enrique Ordieres – President, Cinfa Group, Spain

Enrique Ordieres, president of Cinfa Group, the leading Spanish generics company, highlights the importance of diversification and…

Andrew Corrieri – CEO, Pharmaconsulta, Malta

Andrew Corrieri of Pharmaconsulta in Malta outlines his consultancy’s comprehensive service offering, the opportunities inherent in the Maltese life…

Melissa Barnes & Thomas Cueni on the IFPMA’s New Code…

Eli Lilly and Company's Melissa Barnes, who chairs the Ethics and Business Integrity Committee (eBIC) at the International Federation of…

Mythbusting: Patient Access to Rare Disease Treatments

After her son was diagnosed with SYNGAP1 – an extremely rare gene mutation – Monica founded Bridge the Gap – SYNGAP Education and Research…

Moncef Meklati – General Manager North West Africa, Merck,…

Moncef Meklati, Merck’s general manager for North West Africa, discusses the company's ambitions in the region, the key to successful joint ventures…

Michael Yu – Founder, Chairman and CEO, Innovent Biologics,…

Dr Michael Yu, founder, Chairman and CEO of Innovent Biologics, one of China’s most successful and innovative biopharma start-up, shares his…

Nicolas Bardonnet – General Manager, Promega France

Nicolas Bardonnet of Promega France discusses the standout growth of the company on the occasion of its 40th anniversary, collaboration with…

Sergio Serra Ripol – Managing Director, Tillotts Pharma…

Sergio Serra Ripol, managing director of Tillotts Pharma Spain, highlights the challenges associated with setting up the affiliate and the strategic…

Rogier Janssens – General Manager Biopharma, Merck KGaA,…

Rogier Janssens, GM of the Biopharma business of Merck KGaA, Darmstadt, Germany in China, shares the highlights of his first 16 months at the…

Adrian van den Hoven – Director General, Medicines for…

Over the last ten years, generic medicines have increased access to medicines by over 100% in 7 key therapeutic areas and have provided massive…

Tagged with